Abstract
The objective of this study is to discover the influence of Intellectual Capital (IC) on financial performance of sample pharmaceutical firms in India. Quantitative data of Indian pharmaceutical firms were collected from the audited annual reports for the period from 2007 to 2017. Public (2004) IC model was employed to measure the intellectual capital. Return on Assets, Returnon Equity and Return on Sales were used to measure the financial performance. The study found significant and positive impact of IC on financial performance. The findings of the study would be useful for corporate directors and regulators as well as policy makers to invest in IC, thus leading to higher financial performance. This study is a pioneering attempt to measure the relationship between IC and corporate financial performance in Indian pharmaceutical sector.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
